Research output per year
Research output per year
Personal profile
Research interests
Regulatory science, rare diseases, orphan drugs
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Reply
van den Berg, S., de Visser, S. J., Timmers, L. & Hollak, C. E. M., 1 Jan 2022, In: Value in health. 25, 1, p. 158-159 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Beoordeling van de prijs van een geneesmiddel. Niet alleen op basis van de waarde voor de patiënten
Hollak, C. E. M., van den Berg, S., Timmers, L. & Canoy, M., 17 Sep 2021, In: Nederlands Tijdschrift voor Geneeskunde. 165, 37, D6334.Research output: Contribution to journal › Article › Academic › peer-review
-
Cost-Based Price Calculation of Mexiletine for Nondystrophic Myotonia
van den Berg, S., van der Wel, V., de Visser, S. J., Stunnenberg, B. C., Timmers, L., van der Ree, M. H., Postema, P. G. & Hollak, C. E. M., Jul 2021, In: Value in health. 24, 7, p. 925-929 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Drug Repurposing for Rare Diseases: A Role for Academia
van den Berg, S., de Visser, S., Leufkens, H. G. M. & Hollak, C. E. M., 20 Oct 2021, In: Frontiers in Pharmacology. 12, 746987.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Registries for orphan drugs: generating evidence or marketing tools?
Hollak, C. E. M., Sirrs, S., van den Berg, S., van der Wel, V., Langeveld, M., Dekker, H., Lachmann, R. & de Visser, S. J., 3 Sep 2020, In: Orphanet Journal of Rare Diseases. 15, 1, p. 235 235.Research output: Contribution to journal › Article › Academic › peer-review
Open Access